Tag: funding

IRVINE, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- via IBN -- ECGI Holdings Inc. (OTC: ECGI), a diversified holding company focused on innovation and growth, today announced that its investment arm, Uplist Ventures, was accepted as an affiliate member of TCA Venture Group (formerly Tech Coast Angels). This move positions Uplist Ventures to access one of the most active angel investor networks in the United States, providing exclusive visibility into high-quality early- and growth-stage opportunities.

CTO, CMO and CFO appointments to advance the commercial launch of its precision point-of-care diagnostic Lodestar DX for UTIs worldwide

Lerer Hippeau bets on founder for a second time, Acorns and Betterment Co-Founders join the round with Sway Ventures and FJ Labs

DUBAI, United Arab Emirates, July 21, 2025 (GLOBE NEWSWIRE) --  Little Pepe ($LILPEPE) has just crossed a major milestone, surpassing $10 million in total presale funding as Stage 7 continues at a token price of $0.0016. The project's rapid growth is attracting attention from both retail and institutional crypto investors—not just because of its meme appeal, but also due to the strong utility it offers through its Ethereum-compatible Layer 2 infrastructure.

SINGAPORE, July 21, 2025 (GLOBE NEWSWIRE) -- Further to our announcement filed on Form 6-K on November 20, 2024, CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel donor blood-derived, cell-based allogeneic therapies for the affordable treatment of blood and solid cancers, is pleased to announce the successful completion of dose level 1 for its first-in-human Phase I dose-escalation clinical trial (NCT05302037) (“ANGELICA Trial”) for four late stage cancer patients and is scheduled to start dose level 2 of the ANGELICA Trial in third quarter of 2025.